Although many were on vacation or travelling, about half of the Sutter staff enjoyed taking part in the run in summery weather on June 11, 2015. “We’ll do it again next year”, they enthused.

The Sutter Marketing team attended the European ENT Congress with their own stand and hosted a Sutter Conference with 33 participants in Prague afterwards. At both events, the 4Rhino distributed by Sutter attracted wide interest among visitors and participants.

On May 18, 2015, the German TV channel ARD discussed the much-debated TTIP trade agreement in its documentary broadcast “Die Story”. Bert Sutter, who was one of the representatives of medium-sized companies chosen for an interview, was able to describe the company’s good business relationship with U.S. companies.

Sutter Medizintechnik was honored by the German ENT Society (Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V.) for its longstanding commitment and active contributions to the development and distribution of medical devices in ENT. 

Sutter Medizintechnik has invested over a million euros in machines and new buildings while taking into consideration the latest ergonomic and ecological standards.

After successfully establishing its subsidiary, Sutter Pacific Ltd, in Hong Kong, Sutter will now open a foreign representation in Shenzhen (People’s Republic of China). While the subsidiary in Hong Kong looks after Sutter’s distribution partners in the Asia-Pacific region, the Chinese office will focus on the huge Chinese market. 

With the slogan “Innovations in medical technology” Parliamentary Secretaries of State, Ernst Burgbacher (German Federal Ministry of Economics and Technology), Thomas Ilka (German Federal Ministry of Health) and Dr. Georg Schuette (German Federal Ministry of Education and Research), visited the MEDICA medical show in Duesseldorf this year.

In a prospective, randomized, simple-blinded, placebo-controlled, cross-over study at the ENT university hospital in Mannheim 20 patients that were treated with the CURIS® generator showed significantly better results than those who underwent placebo treatments.

Once in a while you have to celebrate. For our annual company event we met in a remodeled industrial hall for “action painting” this year. In the spirit of Jackson Pollock we gave free rein to our creativity and had a lot of fun. Pieces of our works in acrylic on canvas will soon adorn the rooms on our premises.

On the Sutter premises in Freiburg new facilities for a modern coating plant are being built this year. The new plant will be the forth building on the company grounds. In 2012 a total of more than € 1 million will be invested in buildings and technical equipment. 

Sutter Medizintechnik was again re-certified according to the International Standard ISO 13485:2005 and Annex II of the Medical Device Guideline 93/42/EEC after an intensive audit lasting several days. Additionally Sutter has gained the prestigious CMDCAS certification for Canada. Copies of the certificates can be requested.

Scientists all over the world make daily use of Sutter products. Satisfied customers offer feedback. A number of scientific counselors work with Sutter Medizintechnik to draw up guidelines for common surgical procedures with Sutter products. 

Social responsibility is an established practice for Sutter. Since January a new era has begun: The company pledges to sponsor a child for each person who is employed at Sutter. 

During a symposium on endonasal radiofrequency surgery, more than two hundred ENT surgeons learned about some of the latest developments in energy-based surgery of the nose. The symposium, which was titled “Radiofrequency in the Nose – Turbinates and what is to come in the future?” was held at the 82nd Congress of the German Society of of Otorhinolaryngology, Head and Neck Surgery in Freiburg, Germany. Prof. Boris A. Stuck from the University Hospital Mannheim, Prof. Thomas Kühnel from the University Hospital Regensburg and Prof. Rainer Weber from the Municipal Hospital in Karlsruhe presented their study data and shared their vast experience with the audience. The symposium was sponsored by Sutter Medizintechnik, Germany.

Two new studies confirm the efficacy of Sutter RF systems for turbinate reduction:

In a prospective, randomized, simple-blinded, placebo-controlled, cross-over study at the ENT university hospital in Mannheim 20 patients that were treated with the CURIS® generator showed significantly better results than those who underwent placebo treatments:

Bran et al - RF surgery vs placebo for turbinate reduction 2010 [30 kb]

In a prospective, randomized study on 84 patients who were treated with the BM-780 II at Central Hospital Vasteras, Sweden showed significantly better results than those who received corticoid nasal sprays.

Celiker S. et al - Abstract of RF Treatment vs Steroid Treatment of Chronic Nasal Obstruction [32 kb]

Sutter Medizintechnik has passed the DQS revision audit for the ISO standard 13485 and Annex II of the Medical Device Directive with outstanding results.

Beautiful offices! After a year of modernization, the newly remodelled and enlarged office facilities in Tullastr. 87 and 87a have finally been completed.

"We are glad to be able to work in a newly designed work environment and to have room for more growth”, says Bert Sutter, Managing Director of Sutter Medizintechnik. The modernization has not only led to a visual improvement. Both buildings have also become 20 % more energy-efficient than the strict German low-energy standard requires. A 24 kWp solar station generates green electricity. Environmental sustainability was an important factor in the choice of materials.